Kv Pharmaceutical Company Entered Into an Agreement with Gedeon Richter

KV Pharmaceutical Company on 19 June announced that it entered into an agreement with Gedeon Richter, Plc. of Budapest, Hungary, and jointly with Gedeon Richter USA for licensing rights to some of KV’s technologies and products in Women’s Health.

The agreement deepens the parties’ relationship and allocates Gedeon Richter rights to manufacture and distribute certain of KV’s proprietary technologies and products in its territories, including the European Union. KV Pharmaceutical will receive undisclosed milestones and royalties for products developed under the terms of the agreement.
The agreement also provides for the development of additional products in the future. KV retains the rights to the products and technology in the US.
 

News Monitoring